Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
Astellas Receives Positive CHMP Opinion For PADCEV In Combination With KEYTRUDA For First-Line Treatment Of Advanced Bladder Cancer
AbbVie Exits Alzheimer's Program on Lack of Differentiation
Norfolk Southern Posts Upbeat Earnings, Joins Newell Brands, Charter Communications, 3M And Other Big Stocks Moving Higher On Friday
Analyzing Eli Lilly and Co In Comparison To Competitors In Pharmaceuticals Industry
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
4 Stocks to Watch on Friday: BMY, MMM and More
Freeport-McMoRan, Pfizer, Danaher And An Industrial Stock: CNBC's 'Final Trades'
Today's Morning Movers and Top Ratings: AAPL, MMM, NVDA, COIN and More
Dividend Roundup: Wells Fargo, General Motors, Merck, Delta Air Lines, and More
Bristol-Myers Gains After Q2 Beat and Late-stage Trial Win
US Stocks Look To End Week On High Note As Nvidia Leads Mega-Caps Higher In Premarket Ahead Of Key Inflation Data
Bristol-Myers Squibb in Charts: Q2 Revenue From Eliquis, Opdivo Climb, While Sprycel Falls
Biogen-partnered Alzheimer's Therapy Fails to Clear EU Hurdle
S&P 500, Nasdaq Settle Lower As Tech Stocks Continue To Falter: Greed Index In 'Fear' Zone
Bristol-Myers Squibb, Deckers Outdoor And 3 Stocks To Watch Heading Into Friday
Walt Disney, Eli Lilly, AST SpaceMobile, DexCom, Tesla: Why These 5 Stocks Are On Investors' Radars Today
J&J Talc Bankruptcy Plan Appeal Denied
Novo Nordisk Shares Decline Amid Competitive Pressure
Smart Money Is Betting Big In MRK Options